Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

9.60USD
19 Sep 2018
Change (% chg)

$-0.25 (-2.54%)
Prev Close
$9.85
Open
$9.75
Day's High
$9.85
Day's Low
$9.55
Volume
5,621
Avg. Vol
6,294
52-wk High
$11.55
52-wk Low
$5.75

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Q2 Loss Per Share $0.12
Wednesday, 8 Aug 2018 

Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.12.Q2 REVENUE ROSE 112 PERCENT TO $8.7 MILLION.CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2018 TOTALED $9.5 MILLION.  Full Article

Chembio Diagnostics Appoints Neil Goldman As CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS ANNOUNCES APPOINTMENT OF NEIL A. GOLDMAN AS CHIEF FINANCIAL OFFICER.CHEMBIO DIAGNOSTICS - GOLDMAN SUCCEEDS RICHARD J. LARKIN, WHO HAS SERVED AS CO'S EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER SINCE 2003.  Full Article

Chembio Diagnostics And Astrazeneca Collaborates To Develop Point-Of-Care Diagnostic Test
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Astrazeneca Plc ::CHEMBIO DIAGNOSTICS AND ASTRAZENECA ENTER A COLLABORATION TO DEVELOP POINT-OF-CARE DIAGNOSTIC TEST.CHEMBIO DIAGNOSTICS INC - UNDER TERMS OF 18-MONTH AGREEMENT, CO WILL RECEIVE UP TO $2.9 MILLION IN FUNDING FROM ASTRAZENECA.  Full Article

Chembio Diagnostics Awarded UNICEF Contract
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS.CHEMBIO DIAGNOSTICS INC - ‍CO HAS BEEN AWARDED A CONDITIONAL LONG TERM ARRANGEMENT FROM UNICEF FOR PURCHASES OF COMPANY'S DPP ZIKA SYSTEM​.CHEMBIO DIAGNOSTICS - ‍UNICEF LTA, WHICH IS VALID THROUGH DEC 31, 2019, INCLUDES PURCHASE COMMITMENT OF $1.5 MILLION, POSSIBLE PURCHASES UP TO $3.4 MILLION.  Full Article

Chembio Diagnostics posts Q3 loss of $0.05 per share
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Chembio Diagnostics Inc :Chembio diagnostics reports third quarter 2017 financial results.Q3 loss per share $0.05.Q3 revenue rose 102 percent to $7.6 million.  Full Article